Utah Medical Ownership
| UTMD Stock | USD 56.81 0.60 1.05% |
Shares in Circulation | First Issued 2009-03-31 | Previous Quarter 4 M | Current Value 3 M | Avarage Shares Outstanding 4 M | Quarterly Volatility 126 K |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Utah |
Utah Stock Ownership Analysis
About 71.0% of the company outstanding shares are owned by institutional investors. The company has Price to Book (P/B) ratio of 1.62. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Utah Medical Products last dividend was issued on the 14th of March 2025. The entity had 3:2 split on the 22nd of March 1993. Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company was incorporated in 1978 and is headquartered in Midvale, Utah. Utah Medical operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 178 people. For more information please call Kevin Cornwell at 801 566 1200 or visit https://www.utahmed.com.Besides selling stocks to institutional investors, Utah Medical also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Utah Medical's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Utah Medical's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Utah Medical Quarterly Liabilities And Stockholders Equity |
|
Utah Medical Insider Trades History
About 7.0% of Utah Medical Products are currently held by insiders. Unlike Utah Medical's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Utah Medical's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Utah Medical's insider trades
Utah Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Utah Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Utah Medical Products backward and forwards among themselves. Utah Medical's institutional investor refers to the entity that pools money to purchase Utah Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Minerva Advisors Llc | 2024-12-31 | 78.4 K | Hotchkis & Wiley Capital Management Llc | 2024-12-31 | 75.2 K | Bank Of New York Mellon Corp | 2024-12-31 | 47.3 K | Acadian Asset Management Llc | 2024-12-31 | 43.2 K | Royce & Associates, Lp | 2024-12-31 | 42 K | Northern Trust Corp | 2024-12-31 | 36.8 K | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 36.4 K | Millennium Management Llc | 2024-12-31 | 32.1 K | Isthmus Partners Llc | 2024-12-31 | 31.5 K | Renaissance Technologies Corp | 2024-12-31 | 221.5 K | Dimensional Fund Advisors, Inc. | 2024-12-31 | 186.7 K |
Utah Medical Products Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Utah Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Utah Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Utah Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Leigh Carrie a day ago Insider Trading | ||
Leigh Carrie 2 days ago Insider Trading | ||
Leigh Carrie 3 days ago Insider Trading | ||
Leigh Carrie few days ago Insider Trading | ||
Leigh Carrie few days ago Insider Trading | ||
Leigh Carrie over a week ago Insider Trading | ||
Leigh Carrie over a week ago Insider Trading | ||
Leigh Carrie over a week ago Insider Trading | ||
Leigh Carrie over a week ago Insider Trading | ||
Leigh Carrie over a week ago Insider Trading | ||
Leigh Carrie over two weeks ago Insider Trading | ||
Leigh Carrie over two weeks ago Insider Trading |
Utah Medical Outstanding Bonds
Utah Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Utah Medical Products uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Utah bonds can be classified according to their maturity, which is the date when Utah Medical Products has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| USA Compression Partners Corp BondUS91740PAF53 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Utah Medical Corporate Filings
| 5th of February 2025 Other Reports | ViewVerify | |
8K | 28th of January 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F3 | 12th of November 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
F4 | 8th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Utah Medical Products. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Utah Medical. If investors know Utah will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Utah Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.27) | Dividend Share 1.205 | Earnings Share 3.96 | Revenue Per Share | Quarterly Revenue Growth (0.26) |
The market value of Utah Medical Products is measured differently than its book value, which is the value of Utah that is recorded on the company's balance sheet. Investors also form their own opinion of Utah Medical's value that differs from its market value or its book value, called intrinsic value, which is Utah Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Utah Medical's market value can be influenced by many factors that don't directly affect Utah Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Utah Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Utah Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Utah Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.